Patent · US Active

Device and method for determining analyte levels

US7974672B2 · kind B2 · utility

377Cited by

468References

130Claims

0Family size

Assignee

Dexcom, Inc. · US

Inventors

Mark C. Shults · Madison, US
Stuart J. Updike · Madison, US
Rathbun K. Rhodes · Madison, US

Key dates

Filing date	Apr 19, 2010
Grant date	Jul 5, 2011
Priority date	—
Expiry date	Apr 19, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/006
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.